--- title: Newsroom | Biomanufacturing description: Biomanufacturing | --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (37)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (17)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (254)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (118)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (289)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (154)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (137)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (27)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (88)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates Categories: [Bioprocessing](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing), [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) #### [Takara Bio Europe Introduces GMP-Grade Cellartis® MSC EV Wonder™ to Support Clinical-Scale Extracellular Vesicle Production](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-introduces-gmp-grade-cellartis-msc-ev-wonder-to-support-clinical-scale-extracellular-vesicle-production) October 28, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-introduces-gmp-grade-cellartis-msc-ev-wonder-to-support-clinical-scale-extracellular-vesicle-production) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-introduces-gmp-grade-cellartis-msc-ev-wonder-to-support-clinical-scale-extracellular-vesicle-production#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Oct 28, 2026, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Medical Devices & Technology](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) #### [Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI facility](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) October 22, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Oct 22, 2026, 1:29:59 PM - [Tweet](https://twitter.com/share) Categories: [Bioprocessing](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing), [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [General Laboratory](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory), [Cell Culture](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) #### [Lonza Launches Rapid Custom Media Prototyping Service to Accelerate Early Bioprocess Development](https://news.lifesciencenewswire.com/newsroom/lonza-launches-rapid-custom-media-prototyping-service-to-accelerate-early-bioprocess-development) August 17, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/lonza-launches-rapid-custom-media-prototyping-service-to-accelerate-early-bioprocess-development) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/lonza-launches-rapid-custom-media-prototyping-service-to-accelerate-early-bioprocess-development#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Aug 17, 2026, 2:04:59 PM - [Tweet](https://twitter.com/share) Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jun 16, 2026, 12:01:59 PM - [Tweet](https://twitter.com/share) Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor), [Clinical Diagnostics](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) #### [Medix Biochemica announces $5 million investment to expand recombinant antigen capabilities](https://news.lifesciencenewswire.com/newsroom/medix-biochemica-announces-5-million-investment-to-expand-recombinant-antigen-capabilities) May 18, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/medix-biochemica-announces-5-million-investment-to-expand-recombinant-antigen-capabilities) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/medix-biochemica-announces-5-million-investment-to-expand-recombinant-antigen-capabilities#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 18, 2026, 1:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) #### [Cirena has entered into a licensing agreement with Agilent Technologies, Inc. for long RNA purification technology.](https://news.lifesciencenewswire.com/newsroom/cirena-has-entered-into-a-licensing-agreement-with-agilent-technologies-inc.-for-long-rna-purification-technology) May 7, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cirena-has-entered-into-a-licensing-agreement-with-agilent-technologies-inc.-for-long-rna-purification-technology) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/cirena-has-entered-into-a-licensing-agreement-with-agilent-technologies-inc.-for-long-rna-purification-technology#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on May 7, 2026, 1:04:00 PM - [Tweet](https://twitter.com/share) Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Lonza expands its TheraPEAK® product portfolio with the addition of AmpliCell® Cytokine range and TheraPEAK® 293-GT® Medium](https://news.lifesciencenewswire.com/newsroom/lonza-expands-its-therapeak-product-portfolio-with-the-addition-of-amplicell-cytokine-range-and-therapeak-293-gt-medium) October 6, 2025 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/lonza-expands-its-therapeak-product-portfolio-with-the-addition-of-amplicell-cytokine-range-and-therapeak-293-gt-medium) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/lonza-expands-its-therapeak-product-portfolio-with-the-addition-of-amplicell-cytokine-range-and-therapeak-293-gt-medium#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Oct 6, 2025, 1:05:16 PM - [Tweet](https://twitter.com/share) Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [General Laboratory](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) #### [PromoCell enters the GMP field with custom cell culture media services for cell-based  therapy and regenerative medicine](https://news.lifesciencenewswire.com/newsroom/promocell-enters-the-gmp-field-with-custom-cell-culture-media-services-for-cell-based-therapy-and-regenerative-medicine) September 30, 2025 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/promocell-enters-the-gmp-field-with-custom-cell-culture-media-services-for-cell-based-therapy-and-regenerative-medicine) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/promocell-enters-the-gmp-field-with-custom-cell-culture-media-services-for-cell-based-therapy-and-regenerative-medicine#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Sep 30, 2025, 1:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Biomanufacturing](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma) #### [PHC Corporation of North America to unveil LiCellGrow prototype at Advanced Therapies Week](https://news.lifesciencenewswire.com/newsroom/phc-corporation-of-north-america-to-unveil-licellgrow-prototype-at-advanced-therapies-week) December 10, 2024 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/phc-corporation-of-north-america-to-unveil-licellgrow-prototype-at-advanced-therapies-week) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/phc-corporation-of-north-america-to-unveil-licellgrow-prototype-at-advanced-therapies-week#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 10, 2024, 2:05:00 PM - [Tweet](https://twitter.com/share) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing/page/2) ##### Browse more news ## Recent releases #### [Sciensus Appoints James Tugendhat OBE as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/sciensus-appoints-james-tugendhat-obe-as-chief-executive-officer) October 28, 2026 Sciensus has appointed James Tugendhat OBE as Chief Executive Officer, bringing more than 20 years of leadership experience across healthcare and comp... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sciensus-appoints-james-tugendhat-obe-as-chief-executive-officer) #### [Takara Bio Europe Introduces GMP-Grade Cellartis® MSC EV Wonder™ to Support Clinical-Scale Extracell...](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-introduces-gmp-grade-cellartis-msc-ev-wonder-to-support-clinical-scale-extracellular-vesicle-production) October 28, 2026 Takara Bio Europe announces the introduction of a Good Manufacturing Practice (GMP)-grade version of Cellartis® MSC EV Wonder™, its defined, xeno-free... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/takara-bio-europe-introduces-gmp-grade-cellartis-msc-ev-wonder-to-support-clinical-scale-extracellular-vesicle-production) #### [Samplix Secures Backing to Accelerate Xdrop’s Commercial Expansion in Antibody Discovery](https://news.lifesciencenewswire.com/newsroom/samplix-secures-backing-to-accelerate-xdrops-commercial-expansion-in-antibody-discovery) October 27, 2026 WLan-led financing reaches a €25 million first closing, comprising €3 million in new capital and €22 million in shareholder convertible-bond conversio... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/samplix-secures-backing-to-accelerate-xdrops-commercial-expansion-in-antibody-discovery) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)